Deal Snapshot
CHINA´S SHANGHAI GENEXT MEDICAL TECHNOLOGY TO ACQUIRE LIFELINE SCIENTIFIC FOR USD 87.8M
Wednesday 07 September 2016

US-based transplantation clinical products and services provider Lifeline Scientific, Inc. (AIM: LSIC) has entered into a definitive merger agreement with Chinese medical products company Shanghai Genext Medical Technology Co., Ltd and certain of its affiliates.
SGM is a medical products company serving the field of transplantation in the Asia region. Under the deal, SGM's affiliate would acquire all of the issued and to be issued shares of common stock of LSI for an aggregate consideration of up to approximately USD 87.8m in cash.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 07/09/2016
Target: Lifeline Scientific
Country: USA
Deal Size: 87.8m (USD)
Sector: Healthcare
Type: Corporate acquisition
Financing: Cash
Status: Agreed
Vendor:
Buyer: Shanghai Genext Medical Technology
Buyer Advisor: CITIC Securities Co , BFC Group , Polsinelli PC , King and Wood Mallesons
Comment:


Options